INR 105.3
(3.34%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.82 Billion INR | 9.18% |
2022 | 1.67 Billion INR | 7.75% |
2021 | 1.55 Billion INR | 10.59% |
2020 | 1.4 Billion INR | 15.67% |
2019 | 1.21 Billion INR | 0.11% |
2018 | 1.21 Billion INR | -0.25% |
2017 | 1.21 Billion INR | -3.19% |
2016 | 1.25 Billion INR | -11.96% |
2015 | 1.42 Billion INR | 11.13% |
2014 | 1.28 Billion INR | 1.26% |
2013 | 1.26 Billion INR | 1.72% |
2012 | 1.24 Billion INR | -4.19% |
2011 | 1.3 Billion INR | 0.4% |
2010 | 1.29 Billion INR | -7.74% |
2009 | 1.4 Billion INR | -11.55% |
2008 | 1.58 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 1.82 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 1.83 Billion INR | 0.0% |
2023 FY | 1.82 Billion INR | 9.18% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 1.56 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 FY | 1.67 Billion INR | 7.75% |
2022 Q4 | 1.67 Billion INR | 0.0% |
2021 Q4 | 1.55 Billion INR | 0.0% |
2021 FY | 1.55 Billion INR | 10.59% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 1.45 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 1.4 Billion INR | 15.67% |
2020 Q1 | - INR | -100.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 1.32 Billion INR | 0.0% |
2020 Q4 | 1.4 Billion INR | 0.0% |
2019 FY | 1.21 Billion INR | 0.11% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 1.21 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 1.19 Billion INR | 0.0% |
2018 Q4 | 1.21 Billion INR | 0.0% |
2018 FY | 1.21 Billion INR | -0.25% |
2018 Q1 | - INR | 0.0% |
2017 FY | 1.21 Billion INR | -3.19% |
2016 FY | 1.25 Billion INR | -11.96% |
2015 Q2 | 1.27 Billion INR | 0.0% |
2015 FY | 1.42 Billion INR | 11.13% |
2014 Q1 | - INR | -100.0% |
2014 FY | 1.28 Billion INR | 1.26% |
2014 Q3 | - INR | -100.0% |
2014 Q2 | 1.2 Billion INR | 0.0% |
2014 Q4 | 1.28 Billion INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2013 FY | 1.26 Billion INR | 1.72% |
2013 Q3 | - INR | -100.0% |
2013 Q2 | 1.27 Billion INR | 0.0% |
2013 Q4 | 1.26 Billion INR | 0.0% |
2012 FY | 1.24 Billion INR | -4.19% |
2012 Q4 | 1.24 Billion INR | 0.0% |
2011 FY | 1.3 Billion INR | 0.4% |
2011 Q4 | 1.3 Billion INR | 0.0% |
2010 FY | 1.29 Billion INR | -7.74% |
2009 FY | 1.4 Billion INR | -11.55% |
2008 FY | 1.58 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.786% |
NATCO Pharma Limited | 69.06 Billion INR | 97.356% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 91.898% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 54.871% |
Achyut Healthcare Limited | 309.52 Million INR | -490.012% |
Ajanta Pharma Limited | 46.38 Billion INR | 96.063% |
Alkem Laboratories Limited | 155.74 Billion INR | 98.827% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 97.167% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 83.06% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.595% |
Bajaj HealthCare Limited | 7.65 Billion INR | 76.132% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 84.955% |
Brooks Laboratories Limited | 904.45 Million INR | -101.914% |
Divi's Laboratories Limited | 154.7 Billion INR | 98.82% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.529% |
Eris Lifesciences Limited | 70.48 Billion INR | 97.409% |
FDC Limited | 24.68 Billion INR | 92.601% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 98.728% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 93.593% |
Granules India Limited | 55.2 Billion INR | 96.692% |
Gufic Biosciences Limited | 10.92 Billion INR | 83.285% |
Hester Biosciences Limited | 6.62 Billion INR | 72.428% |
Indoco Remedies Limited | 21.44 Billion INR | 91.485% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 84.326% |
Ipca Laboratories Limited | 111.01 Billion INR | 98.355% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | 15.873% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -2.496% |
Lasa Supergenerics Limited | 1.5 Billion INR | -21.047% |
Laurus Labs Limited | 83.87 Billion INR | 97.823% |
Lupin Limited | 239.97 Billion INR | 99.239% |
Mankind Pharma Limited | 119.63 Billion INR | 98.473% |
Medicamen Biotech Limited | 2.94 Billion INR | 37.994% |
Medico Remedies Limited | 961.95 Million INR | -89.845% |
Megasoft Limited | 3.65 Billion INR | 50.09% |
Piramal Pharma Limited | 153.11 Billion INR | 98.807% |
RPG Life Sciences Limited | 5.12 Billion INR | 64.392% |
Sigachi Industries Limited | 6.94 Billion INR | 73.692% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 64.542% |
Unichem Laboratories Limited | 31.69 Billion INR | 94.238% |
Wanbury Limited | 3.43 Billion INR | 46.834% |
Windlas Biotech Limited | 6.26 Billion INR | 70.837% |
ZIM Laboratories Limited | 4.46 Billion INR | 59.129% |
Zydus Lifesciences Limited | 292.8 Billion INR | 99.376% |
Procter & Gamble Health Limited | 7.94 Billion INR | 77.01% |
Amrutanjan Health Care Limited | 3.66 Billion INR | 50.222% |
Bal Pharma Limited | 3.2 Billion INR | 43.0% |
Strides Pharma Science Limited | 58.39 Billion INR | 96.873% |
Venus Remedies Limited | 6.26 Billion INR | 70.866% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 92.927% |
Nectar Lifesciences Limited | 21.91 Billion INR | 91.665% |
Shilpa Medicare Limited | 30.93 Billion INR | 94.096% |
Aarti Drugs Limited | 24.32 Billion INR | 92.492% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 91.863% |
Suven Life Sciences Limited | 2.84 Billion INR | 35.9% |
Ind-Swift Limited | 6.54 Billion INR | 72.096% |
Valiant Laboratories Limited | 3.42 Billion INR | 46.709% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 95.428% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | 92.232% |
Themis Medicare Limited | 5.66 Billion INR | 67.758% |
Hikal Limited | 24.87 Billion INR | 92.657% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 98.787% |
Sequent Scientific Limited | 15.4 Billion INR | 88.144% |
Novartis India Limited | 9.24 Billion INR | 80.256% |
Wockhardt Limited | 76.49 Billion INR | 97.612% |
Jubilant Pharmova Limited | 115.48 Billion INR | 98.419% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -287.874% |
Neuland Laboratories Limited | 18.32 Billion INR | 90.035% |
Morepen Laboratories Limited | 12.93 Billion INR | 85.878% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | 23.927% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | 45.228% |